We are live on ! Find out more
MDT icon

Medtronic

1,563 hedge funds and large institutions have $99B invested in Medtronic in 2018 Q4 according to their latest regulatory filings, with 200 funds opening new positions, 630 increasing their positions, 523 reducing their positions, and 108 closing their positions.

New
Increased
Maintained
Reduced
Closed

85% more first-time investments, than exits

New positions opened: 200 | Existing positions closed: 108

21% more funds holding in top 10

Funds holding in top 10: 6680 (+14)

20% more repeat investments, than reductions

Existing positions increased: 630 | Existing positions reduced: 523

5% more funds holding

Funds holding: 1,4841,563 (+79)

4% more call options, than puts

Call options by funds: $669M | Put options by funds: $645M

0.05% more ownership

Funds ownership: 81.75%81.81% (+0.05%)

9% less capital invested

Capital invested by funds: $109B → $99B (-$9.73B)

Holders
1,563
Holders Change
+79
Holders Change %
+5.32%
% of All Funds
34.83%
Holding in Top 10
80
Holding in Top 10 Change
+14
Holding in Top 10 Change %
+21.21%
% of All Funds
1.78%
New
200
Increased
630
Reduced
523
Closed
108
Calls
$669M
Puts
$645M
Net Calls
+$24.4M
Net Calls Change
+$84.1M
Name Holding Trade Value Shares
Change
Change in
Stake
OI
201
Oakbrook Investments
Illinois
$36.3M -$2.42M -25,950 -6%
CCMG
202
Clark Capital Management Group
Pennsylvania
$35.3M +$787K +8,421 +2%
Macquarie Group
203
Macquarie Group
Australia
$35.2M +$4.52M +48,321 +14%
SRIM
204
Saratoga Research & Investment Management
California
$35.2M -$2.15M -23,057 -6%
William Blair & Company
205
William Blair & Company
Illinois
$35.1M +$710K +7,596 +2%
SOMRS
206
State of Michigan Retirement System
Michigan
$35M -$1.67M -17,900 -4%
MIM
207
MetLife Investment Management
New Jersey
$34.9M -$820K -8,774 -2%
WA
208
WestEnd Advisors
North Carolina
$34.6M -$4.63M -49,528 -12%
JFL
209
Jarislowsky, Fraser Ltd
Quebec, Canada
$34.2M -$573K -6,128 -2%
DFO
210
Duquesne Family Office
New York
$33.9M
HSBC Holdings
211
HSBC Holdings
United Kingdom
$33.5M +$5.36M +57,319 +18%
SW
212
SVB Wealth
Massachusetts
$32.9M -$486K -5,206 -1%
SL
213
Summitry LLC
California
$32.3M -$1.03M -11,041 -3%
RMDI
214
R.M. Davis Inc
Maine
$32.2M +$74.8K +800 +0.2%
GAM
215
Gotham Asset Management
New York
$31.9M -$29.2M -312,943 -47%
KFC
216
Klingenstein Fields & Co
New York
$31.5M +$1.32M +14,099 +4%
ASRS
217
Arizona State Retirement System
Arizona
$31.1M -$5.25M -56,156 -14%
Luther King Capital Management (LKCM)
218
Luther King Capital Management (LKCM)
Texas
$31M -$280K -2,992 -0.9%
ZIG
219
Zurich Insurance Group
Switzerland
$29.8M +$5.97M +63,922 +24%
GIBU
220
Gulf International Bank (UK)
United Kingdom
$29.4M -$13.2M -140,802 -30%
CGH
221
Crossmark Global Holdings
Texas
$29.4M +$735K +7,867 +2%
Assenagon Asset Management
222
Assenagon Asset Management
Luxembourg
$29.1M +$27.2M +291,517 +1,039%
Teacher Retirement System of Texas
223
Teacher Retirement System of Texas
Texas
$29M +$481K +5,146 +2%
FAF
224
Fjarde Ap-fonden
Sweden
$28.9M -$4.12M -44,100 -12%
CCM
225
Compass Capital Management
Minnesota
$28.8M +$412K +4,407 +1%

MDT Hedge Fund Activity: Q4 2018 in Review

1,563 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Medtronic (MDT) for Q4 2018, worth a combined $99B — down 9% from $109B a quarter earlier.

Buyers outnumbered sellers: 200 funds opened new MDT positions and 108 closed out — a net gain of 92 holders — while 630 added to existing stakes and 523 trimmed.

The largest buyer was Vanguard Group, adding an estimated $237M. The largest seller was Dodge & Cox, cutting an estimated $1.09B.

  • 1,563 institutional investors held Medtronic (MDT) as of Q4 2018, up from 1,484 in Q3 2018.
  • Funds reported $99B of Medtronic stock for Q4 2018, down 9% quarter-over-quarter.
  • 200 funds opened new Medtronic positions in Q4 2018 and 108 closed out, a net change of +92 holders.
  • The largest Medtronic buyer in Q4 2018 was Vanguard Group, an estimated $237M added.
  • The largest Medtronic seller in Q4 2018 was Dodge & Cox, an estimated $1.09B sold.

Based on aggregated 13F filings for Q4 2018.